News | Treatment Planning | May 10, 2016

MIM Maestro software suite offers advanced tools for image fusion, contouring, deformable registration and automation

May 10, 2016 — MIM Software Inc. announced that GenesisCare Australia has selected MIM Maestro as their radiotherapy contouring and deformable registration solutions platform across the Genesis Cancer Care Network in Australia.

Genesis Cancer Care is the largest provider of radiotherapy in Australia, performing over 300,000 yearly radiation oncology treatments from its network of 27 sites across the region. An extensive evaluation led to MIM Software being selected as the preferred suite of products to address the increasing demands of complex treatment protocols, resource-intensive workflows and high patient volumes.

"We are very excited to be partnering with MIM Software," explained Keith Hansen, national executive manager at Genesis Cancer Care. "A great deal of time and effort was spent in evaluating an optimal solution that would allow us to incorporate advanced processes and technologies into our patient care workflows. We are continuously striving to provide high-quality care for patients, with clinical excellence in image management and treatment planning, a key outcome required of the partnership. By implementing MIM into our clinics we will ensure every patient in our care receives highly personalised and highly targeted treatments."

MIM Maestro is a medical software suite capable of solving complex problems through the use of advanced tools for image fusion, contouring, deformable registration and automation to enhance radiation therapy plans.

For more information: www.mimsoftware.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now